Characterization of a Potential Drug Target in Entamoeba histolytica
Author Information
Author(s): Jhingran Anupam, Padmanabhan Prasad K., Singh Sushma, Anamika Krishanpal, Bakre Abhijeet A., Bhattacharya Sudha, Bhattacharya Alok, Srinivasan Narayanaswamy, Madhubala Rentala
Primary Institution: Jawaharlal Nehru University, New Delhi, India
Hypothesis
The study aims to characterize the ornithine decarboxylase-like enzyme in Entamoeba histolytica as a potential drug target.
Conclusion
The molecular characterization of the putative ODC-like enzyme from E. histolytica suggests it has evolved a novel substrate specificity and is not inhibited by DFMO.
Supporting Evidence
- The putative ODC-like sequence has 33% sequence identity with human ODC.
- The enzyme is a single-copy gene located on a 1.9-Mb chromosome.
- DFMO had no effect on the recombinant putative ODC from E. histolytica.
- Computer modeling revealed critical residues for DFMO binding are substituted in E. histolytica.
Takeaway
Researchers studied a protein in a tiny germ that makes people sick, and they found it might not work like similar proteins in humans, which could help in making new medicines.
Methodology
The gene encoding the putative ornithine decarboxylase-like sequence was cloned, expressed in E. coli, and characterized through various biochemical assays.
Limitations
The recombinant putative ODC was unstable, and the study could not determine its activity with certain substrates.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website